purchase customization

Leave This Empty:

choose chapter to purchase

table of content

1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Injectable Targeted Therapy Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Monoclonal Antibodies
1.2.3 Small-Molecules
1.2.4 Immunotoxins
1.2.5 Others
1.3 Market by Application
1.3.1 Global Injectable Targeted Therapy Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospitals
1.3.3 Homecare
1.3.4 Specialty Clinics
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Injectable Targeted Therapy Market Perspective (2017-2028)
2.2 Injectable Targeted Therapy Growth Trends by Region
2.2.1 Injectable Targeted Therapy Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Injectable Targeted Therapy Historic Market Size by Region (2017-2022)
2.2.3 Injectable Targeted Therapy Forecasted Market Size by Region (2023-2028)
2.3 Injectable Targeted Therapy Market Dynamics
2.3.1 Injectable Targeted Therapy Industry Trends
2.3.2 Injectable Targeted Therapy Market Drivers
2.3.3 Injectable Targeted Therapy Market Challenges
2.3.4 Injectable Targeted Therapy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Injectable Targeted Therapy Players by Revenue
3.1.1 Global Top Injectable Targeted Therapy Players by Revenue (2017-2022)
3.1.2 Global Injectable Targeted Therapy Revenue Market Share by Players (2017-2022)
3.2 Global Injectable Targeted Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Injectable Targeted Therapy Revenue
3.4 Global Injectable Targeted Therapy Market Concentration Ratio
3.4.1 Global Injectable Targeted Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Injectable Targeted Therapy Revenue in 2021
3.5 Injectable Targeted Therapy Key Players Head office and Area Served
3.6 Key Players Injectable Targeted Therapy Product Solution and Service
3.7 Date of Enter into Injectable Targeted Therapy Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Injectable Targeted Therapy Breakdown Data by Type
4.1 Global Injectable Targeted Therapy Historic Market Size by Type (2017-2022)
4.2 Global Injectable Targeted Therapy Forecasted Market Size by Type (2023-2028)
5 Injectable Targeted Therapy Breakdown Data by Application
5.1 Global Injectable Targeted Therapy Historic Market Size by Application (2017-2022)
5.2 Global Injectable Targeted Therapy Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Injectable Targeted Therapy Market Size (2017-2028)
6.2 North America Injectable Targeted Therapy Market Size by Type
6.2.1 North America Injectable Targeted Therapy Market Size by Type (2017-2022)
6.2.2 North America Injectable Targeted Therapy Market Size by Type (2023-2028)
6.2.3 North America Injectable Targeted Therapy Market Share by Type (2017-2028)
6.3 North America Injectable Targeted Therapy Market Size by Application
6.3.1 North America Injectable Targeted Therapy Market Size by Application (2017-2022)
6.3.2 North America Injectable Targeted Therapy Market Size by Application (2023-2028)
6.3.3 North America Injectable Targeted Therapy Market Share by Application (2017-2028)
6.4 North America Injectable Targeted Therapy Market Size by Country
6.4.1 North America Injectable Targeted Therapy Market Size by Country (2017-2022)
6.4.2 North America Injectable Targeted Therapy Market Size by Country (2023-2028)
6.4.3 U.S.
6.4.4 Canada
7 Europe
7.1 Europe Injectable Targeted Therapy Market Size (2017-2028)
7.2 Europe Injectable Targeted Therapy Market Size by Type
7.2.1 Europe Injectable Targeted Therapy Market Size by Type (2017-2022)
7.2.2 Europe Injectable Targeted Therapy Market Size by Type (2023-2028)
7.2.3 Europe Injectable Targeted Therapy Market Share by Type (2017-2028)
7.3 Europe Injectable Targeted Therapy Market Size by Application
7.3.1 Europe Injectable Targeted Therapy Market Size by Application (2017-2022)
7.3.2 Europe Injectable Targeted Therapy Market Size by Application (2023-2028)
7.3.3 Europe Injectable Targeted Therapy Market Share by Application (2017-2028)
7.4 Europe Injectable Targeted Therapy Market Size by Country
7.4.1 Europe Injectable Targeted Therapy Market Size by Country (2017-2022)
7.4.2 Europe Injectable Targeted Therapy Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Injectable Targeted Therapy Market Size (2017-2028)
8.2 Asia-Pacific Injectable Targeted Therapy Market Size by Type
8.2.1 Asia-Pacific Injectable Targeted Therapy Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Injectable Targeted Therapy Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Injectable Targeted Therapy Market Share by Type (2017-2028)
8.3 Asia-Pacific Injectable Targeted Therapy Market Size by Application
8.3.1 Asia-Pacific Injectable Targeted Therapy Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Injectable Targeted Therapy Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Injectable Targeted Therapy Market Share by Application (2017-2028)
8.4 Asia-Pacific Injectable Targeted Therapy Market Size by Region
8.4.1 Asia-Pacific Injectable Targeted Therapy Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Injectable Targeted Therapy Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Injectable Targeted Therapy Market Size (2017-2028)
9.2 Latin America Injectable Targeted Therapy Market Size by Type
9.2.1 Latin America Injectable Targeted Therapy Market Size by Type (2017-2022)
9.2.2 Latin America Injectable Targeted Therapy Market Size by Type (2023-2028)
9.2.3 Latin America Injectable Targeted Therapy Market Share by Type (2017-2028)
9.3 Latin America Injectable Targeted Therapy Market Size by Application
9.3.1 Latin America Injectable Targeted Therapy Market Size by Application (2017-2022)
9.3.2 Latin America Injectable Targeted Therapy Market Size by Application (2023-2028)
9.3.3 Latin America Injectable Targeted Therapy Market Share by Application (2017-2028)
9.4 Latin America Injectable Targeted Therapy Market Size by Country
9.4.1 Latin America Injectable Targeted Therapy Market Size by Country (2017-2022)
9.4.2 Latin America Injectable Targeted Therapy Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Injectable Targeted Therapy Market Size (2017-2028)
10.2 Middle East & Africa Injectable Targeted Therapy Market Size by Type
10.2.1 Middle East & Africa Injectable Targeted Therapy Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Injectable Targeted Therapy Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Injectable Targeted Therapy Market Share by Type (2017-2028)
10.3 Middle East & Africa Injectable Targeted Therapy Market Size by Application
10.3.1 Middle East & Africa Injectable Targeted Therapy Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Injectable Targeted Therapy Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Injectable Targeted Therapy Market Share by Application (2017-2028)
10.4 Middle East & Africa Injectable Targeted Therapy Market Size by Country
10.4.1 Middle East & Africa Injectable Targeted Therapy Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Injectable Targeted Therapy Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Novartis
11.1.1 Novartis Company Details
11.1.2 Novartis Business Overview
11.1.3 Novartis Injectable Targeted Therapy Introduction
11.1.4 Novartis Revenue in Injectable Targeted Therapy Business (2017-2022)
11.1.5 Novartis Recent Developments
11.2 Sanofi
11.2.1 Sanofi Company Details
11.2.2 Sanofi Business Overview
11.2.3 Sanofi Injectable Targeted Therapy Introduction
11.2.4 Sanofi Revenue in Injectable Targeted Therapy Business (2017-2022)
11.2.5 Sanofi Recent Developments
11.3 GSK
11.3.1 GSK Company Details
11.3.2 GSK Business Overview
11.3.3 GSK Injectable Targeted Therapy Introduction
11.3.4 GSK Revenue in Injectable Targeted Therapy Business (2017-2022)
11.3.5 GSK Recent Developments
11.4 Bayer
11.4.1 Bayer Company Details
11.4.2 Bayer Business Overview
11.4.3 Bayer Injectable Targeted Therapy Introduction
11.4.4 Bayer Revenue in Injectable Targeted Therapy Business (2017-2022)
11.4.5 Bayer Recent Developments
11.5 Amgen
11.5.1 Amgen Company Details
11.5.2 Amgen Business Overview
11.5.3 Amgen Injectable Targeted Therapy Introduction
11.5.4 Amgen Revenue in Injectable Targeted Therapy Business (2017-2022)
11.5.5 Amgen Recent Developments
11.6 Merck
11.6.1 Merck Company Details
11.6.2 Merck Business Overview
11.6.3 Merck Injectable Targeted Therapy Introduction
11.6.4 Merck Revenue in Injectable Targeted Therapy Business (2017-2022)
11.6.5 Merck Recent Developments
11.7 AbbiVie
11.7.1 AbbiVie Company Details
11.7.2 AbbiVie Business Overview
11.7.3 AbbiVie Injectable Targeted Therapy Introduction
11.7.4 AbbiVie Revenue in Injectable Targeted Therapy Business (2017-2022)
11.7.5 AbbiVie Recent Developments
11.8 AstraZeneca
11.8.1 AstraZeneca Company Details
11.8.2 AstraZeneca Business Overview
11.8.3 AstraZeneca Injectable Targeted Therapy Introduction
11.8.4 AstraZeneca Revenue in Injectable Targeted Therapy Business (2017-2022)
11.8.5 AstraZeneca Recent Developments
11.9 Teva
11.9.1 Teva Company Details
11.9.2 Teva Business Overview
11.9.3 Teva Injectable Targeted Therapy Introduction
11.9.4 Teva Revenue in Injectable Targeted Therapy Business (2017-2022)
11.9.5 Teva Recent Developments
11.10 Roche
11.10.1 Roche Company Details
11.10.2 Roche Business Overview
11.10.3 Roche Injectable Targeted Therapy Introduction
11.10.4 Roche Revenue in Injectable Targeted Therapy Business (2017-2022)
11.10.5 Roche Recent Developments
11.11 Pfizer
11.11.1 Pfizer Company Details
11.11.2 Pfizer Business Overview
11.11.3 Pfizer Injectable Targeted Therapy Introduction
11.11.4 Pfizer Revenue in Injectable Targeted Therapy Business (2017-2022)
11.11.5 Pfizer Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer